产品详情
文献和实验
相关推荐
英文名 :SpCas9 Nuclease
规格 :100 ug
SpCas9 Nuclease,SpCas9核酸酶,用于基因编辑的Cas9蛋白jetCRISPR™
RNP transfection reagent for genome editing
- Specifically designed for Cas protein (Cas9, Cpf1) and guide RNA delivery
- High genome editing efficiency
- Excellent cell viability and morphology
- Fast and reliable gene editing
- Easy to use: Reverse and Forward protocols
Specifications
Reagent | jetCRISPR™ |
---|---|
Molecule delivered | Ribonucleoprotein: Guide RNA and Cas protein (Cas9, Cpf1) |
Application | CRISPR mediated Genome editing |
Cell types | Adherent and suspension cells |
Number of transfections | 1.5 ml of jetCRISPR™ transfection reagent is sufficient to perform up to 1250 transfections in 24-well plates or 300 transfections in 6-well plates |
Storage | 5°C ± 3°C, stable for 6 months (502-01) to at least one year (other packaging sizes) when stored appropriately |
Summary
CRISPR/Cas engineered nuclease system is a powerful and highly specific genome editing tool. CRISPR/Cas is a two component system with a guide RNA (gRNA) molecule that drives a Cas nuclease (Cas9, Cpf1) to a specific targeted sequence within the genome in order to introduce genetic modifications (mutations, insertions or deletions).
jetCRISPR™ is an innovative reagent especially designed to deliver RNP in a CRISPR/Cas9 and CRISPR/Cpf1 experiments. jetCRISPR™ leads to high CRISPR genome editing efficiency, while maintaining excellent cell viability and morphology post-transfection. Use the leading technology for CRISPR/Cas9 and CRISPR/Cpf1 RNP delivery!
Increase your CRISPR/Cas9 genome editing efficiency using SpCas9 Nuclease!
Ordering information
Product | Reference Number | Product size |
---|---|---|
jetCRISPR™ | 502-01 | 0.1 ml |
jetCRISPR™ | 502-07 | 0.75 ml |
jetCRISPR™ | 502-15 | 1.5 ml |
SpCas9 Nuclease | 722-100 | 100 µg |
High Genome Editing efficiency
jetCRISPR™ has been specifically designed for high transfection efficiency of RNP (guide RNA and Cas9 protein complex), thus leading to a high cas9-mediated genome editing efficiency on a wide variety of targets in different cell types (Fig. 1 & 2).
Fig. 1: High genome editing efficiency using jetCRISPR™ in HeLa cells. RNP transfections were performed in HeLa cells using several RNP concentrations of SpCas9 Nuclease and HPRT1 sgRNA or negative control in combination with 0.3 µl of jetCRISPR™ reagent per well of a 96-well plate. At 48 h post-transfection, T7 digestion products were run on a 2% agarose gel and stained with BET displayed by G:Box transilluminator (Syngene®). Acquisitions were carried out with the Genesnap software (Syngene®) and INDEL quantifications were performed with the Genetools software (Syngene®). 1: Uncleaved fragment of 1083 bp, 2: long cleaved fragment of 827 bp, 3: short cleaved fragment of 256 bp.jetCRISPR™ transfection reagent achieves higher genome editing efficiency than other competitors, which makes it the product of choice for CRISPR applications.
Fig. 2: Superior genome editing efficiency obtained with jetCRISPR™ in comparison with Lipofectamine® CRISPRMAX™. RNP transfections were performed in A549 and HEK-293 cells using 30 nM RNP (SpCas9 Nuclease and HPRT1 sgRNA) with 0.3 µl of jetCRISPR™ reagent or 0.3 µl of Lipofectamine® CRISPRMAX™, per well of a 96-well plate. At 48 h post-transfection, genome editing was assessed by calculating the percentage (%) of INDEL using the T7 endonuclease method. The INDEL % was determined by using Genetools software (Syngene®).上海研卉生物科技有限公司
实名认证
金牌会员
入驻年限:10年